FOXO1 and breast cancer: When BC cells were treated with the inhibitor LY294002, the protein level of p-FOXO1 was decreased (EJ, P<0.01 and UMUC3, P<0.05; Figure 3D), while no significant change was observed in the protein level of total FOXO1, indicating that the amount of active FOXO1 was increased.